Chemistry-Biology Interface Training Program at the University of Florida
Chemistry-Biology Interface Training Program at the University of Florida
批准号:
10633239
负责人:
Chenglong Li
金额:
$17.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-01 至 2025-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The University of Florida Chemistry-Biology Interface (UF-CBI) Training Program is
primarily a partnership between the Department of Medicinal Chemistry and the Department of
Chemistry and takes advantage of the existing recruiting and academic training frameworks
provided by these graduate programs, and the recent expansion in junior and senior research
training faculty across campus. The overarching goal of the program is to develop and expand a
diverse and talented pool of professional researchers with the skills to pursue successful careers
in the biomedical workforce. The UF-CBI Training Plan proposes a series of high impact training
experiences designed to enhance existing departmental predoctoral training activities, and
broadly impact all students in the participating programs. Key elements include: core courses
within a flexible and customizable curriculum; monthly research in progress seminars;
participation in the yearly UF Drug Discovery Symposium, and biennial Florida Heterocyclic and
Synthetic Chemistry Conference, a yearly orientation providing a forum for feedback; training in
rigor and reproducibility, training in scientific communication skills, and a continuing commitment
to inclusion, diversity, and science outreach. Benchmarks for success will be an increasingly
diverse cohort of UF-CBI Trainees and Faculty Trainers, the highest level of retention for all
trainees, a high level of research productivity, and successful transition into biomedical research
careers that fully capitalize on their doctoral training. Critical evaluation of these benchmarks will
be achieved through the implementation of a quantitative assessment plan.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/anie.202203784
发表时间:
2022-10-04
期刊:
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子:
16.6
作者:
[Pritzlaff, Amanda, Ferre, Guillaume, Mulry, Emma, Lin, Ling, Pour, Niloofar Gopal, Savin, Daniel A., Harris, Michael E., Eddy, Matthew T.]
通讯作者:
Eddy, Matthew T.
DOI:
10.1021/acsomega.1c02480
发表时间:
2021-08-10
期刊:
ACS omega
影响因子:
4.1
作者:
[Norwood VM 4th, Murillo-Solano C, Goertzen MG 2nd, Brummel BR, Perry DL, Rocca JR, Chakrabarti D, Huigens RW 3rd]
通讯作者:
Huigens RW 3rd
DOI:
10.1016/j.jep.2022.115514
发表时间:
2022-10-28
期刊:
JOURNAL OF ETHNOPHARMACOLOGY
影响因子:
5.4
作者:
[Kanumuri, Siva Rama Raju, Mamallapalli, Jessica, Nelson, Robyn, McCurdy, Christopher R., Mathews, Carol A., Xing, Chengguo, Sharma, Abhisheak]
通讯作者:
Sharma, Abhisheak
DOI:
10.1021/acscatal.1c01113
发表时间:
2021-05-21
期刊:
ACS catalysis
影响因子:
12.9
作者:
[Xu B, Li Z, Alsup TA, Ehrenberger MA, Rudolf JD]
通讯作者:
Rudolf JD
Chemistry-Biology Interface Training Program at the University of Florida
-
批准号:10425279
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2020
-
负责人:Chenglong Li
-
依托单位:
Chemistry-Biology Interface Training Program at the University of Florida
-
批准号:10163217
-
项目类别:
-
资助金额:$16.23万
-
财政年份:2020
-
负责人:Chenglong Li
-
依托单位:
A novel STAT3-selective inhibitor for medulloblastoma therapy
-
批准号:9551096
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2016
-
负责人:Chenglong Li
-
依托单位:
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy
-
批准号:9057630
-
项目类别:
-
资助金额:$14.05万
-
财政年份:2015
-
负责人:Chenglong Li
-
依托单位:
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy
-
批准号:8887773
-
项目类别:
-
资助金额:$47.11万
-
财政年份:2015
-
负责人:Chenglong Li
-
依托单位:
Small molecule in vivo probe development targeting the IL-6/STAT3 pathway for potential multiple sclerosis therapy
-
批准号:9421608
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2015
-
负责人:Chenglong Li
-
依托单位:
Novel lead molecule optimization targeting nicotinic receptor subtypes
-
批准号:7781228
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2009
-
负责人:Chenglong Li
-
依托单位:
Target Stat3 in pancreatic cancer using novel small molecule inhibitors
-
批准号:7661258
-
项目类别:
-
资助金额:$20.28万
-
财政年份:2009
-
负责人:Chenglong Li
-
依托单位:
Novel lead molecule optimization targeting nicotinic receptor subtypes
-
批准号:8109582
-
项目类别:
-
资助金额:$1.07万
-
财政年份:2009
-
负责人:Chenglong Li
-
依托单位:
Target Stat3 in pancreatic cancer using novel small molecule inhibitors
-
批准号:7753175
-
项目类别:
-
资助金额:$16.1万
-
财政年份:2009
-
负责人:Chenglong Li
-
依托单位:
国内基金
海外基金
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
Science China Chemistry
-
批准号:21024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:朱晓文
-
依托单位:
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
-
批准号:20974058
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:2009
-
负责人:袁金颖
-
依托单位: